Efficacy and Safety of Gilteritinib versus Sorafenib as Post-Transplant Maintenance in Patients With FLT3-ITD Acute Myeloid Leukemia

Jason Yeh, Oren Pasvolsky, Rima M. Saliba, Bradley Figgins, Christopher Wang, Zhou Fang, Sairah Ahmed, Musa Yilmaz, Naval Daver, Farhad Ravandi, Courtney DiNardo, Nicholas J. Short, Tapan Kadia, Gheath Al-Atrash, May Daher, David Marin Costa, Uday Popat, Richard Champlin, Elizabeth Shpall, Betül Oran*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and Safety of Gilteritinib versus Sorafenib as Post-Transplant Maintenance in Patients With FLT3-ITD Acute Myeloid Leukemia'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science